[1]
J. Gubaljevic, “Serum levels of oxidative stress marker malondialdehyde in breast cancer patients in relation to pathohistological factors, estrogen receptors, menopausal status, and age”, JHSCI, vol. 8, no. 3, pp. 154–161, Dec. 2018.